Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
62.46 EUR | -0.64% |
|
+1.98% | -8.10% |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.10% | 8.61B | - | ||
-3.41% | 1.36B | D | ||
-11.94% | 1.3B | B+ | ||
-0.64% | 1.23B | - | ||
-30.35% | 729M | - | - | |
-.--% | 615M | - | - | |
+7.32% | 482M | - | ||
+2.83% | 437M | - | - | |
-35.03% | 287M | - | - | |
-66.61% | 262M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- HS2 Stock
- Ratings Henry Schein, Inc.